Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Bristol Myers Squibb (BMY)’

Gilead Sciences, Inc. (NASDAQ:GILD)

David Kim’s Ghost Tree Capital Loves These Healthcare Stocks

Ghost Tree Capital is a healthcare-oriented hedge fund headquartered in New York. It was founded in 2013 by David Kim who is the portfolio manager, Ken......(read more)
RENAISSANCE TECHNOLOGIES

Renaissance Technologies’s Long Term Stock Picks Include McDonald’s Corporation (MCD)

We track quarterly 13F filings from hundreds of hedge funds and other notable investors, including Renaissance Technologies, the highly successful hedge......(read more)
RENAISSANCE TECHNOLOGIES

Renaissance Technologies LLC Bought International Business Machines Corp. (IBM), Sold QUALCOMM, Inc. (QCOM) During The First Quarter

Jim Simons founded Renaissance Technologies LLC in 1982 and has since become a multi-billionaire due to the fund’s success over time even as it has......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): AbbVie Inc (ABBV) Insiders Are Buying, Should You?

AbbVie Inc (NYSE:ABBV) investors should be aware of an increase in hedge fund sentiment of late, and we’ll compare the company to peers like GlaxoSmithKline......(read more)

A Board Member Added 20,000 Shares of Gilead

Gilead Sciences, Inc. (NASDAQ:GILD) Board member Per Wold-Olsen has bought 20,000 shares of the company’s stock in the past couple weeks, according......(read more)
Izzy Englander of MILLENNIUM MANAGEMENT

A Board Member Bought Over $300,000 of Abbott Labs

A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and......(read more)
Ken Fisher - FISHER ASSET MANAGEMENT

Ken Fisher & Jim Simons: Two Billionaires Bulking Up On Drugs

Billionaires Ken Fisher and Jim Simons are two of the top names in the money management business. Fisher runs Fisher Asset Management and is also a long......(read more)
RENAISSANCE TECHNOLOGIES

Microsoft Corporation (MSFT), Intel Corporation (INTC) Among This Mega-Hedge Fund’s Top Picks

Earlier this month billionaire Jim Simons and his firm Renaissance Technologies filed its third quarter 13F, where notable investors and hedge funds are......(read more)
is autozone a good stock to buy?

Jim Cramer Likes These Growth Stocks

If a stock has a high trailing price-to-earnings multiple, that generally indicates that it is a growth stock- that the market expects its earnings to......(read more)
RENAISSANCE TECHNOLOGIES

Is Bristol Myers Squibb a Good Stock to Buy?

Bristol Myers Squibb Co. (NYSE:BMY) is down 5% so far this year, as the company saw bad news break in early August when it suspended a trial for its prospective......(read more)
FISHER ASSET MANAGEMENT

Is Pfizer a Good Stock to Buy?

Pfizer Inc. (NYSE:PFE) is up 5% over the last month and is now making a push towards a $200 billion market capitalization. The large drug manufacturer......(read more)
FAIRHOLME (FAIRX) Bruce Berkowitz

Bruce Berkowitz is Bullish About Eli Lilly $LLY

Bruce Berkowitz, founder and manager of the Fairholme fund has had a change of heart. Berkowitz has gone from bull to bear on pharmaceutical stocks....(read more)
RENAISSANCE TECHNOLOGIES

20 High Dividend Stocks That Analysts Recommend

Defensive investors like high dividend yielding stocks and consider them as viable options especially in inflationary environments. We are concerned about......(read more)
is autozone a good stock to buy?

Jim Cramer’s Latest Stock Picks

Jim Cramer’s latest stock picks are getting more cautious. Jim Cramer talked about Steve Jobs’ death and Apple’s future on his show,......(read more)